Caitong International Asset Management Co., LTD Maxcyte, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Maxcyte, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 163 shares of MXCT stock, worth $679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163
Previous 163
-0.0%
Holding current value
$679
Previous $678,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
122Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$39 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$22.6 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$21 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$18.4 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $424M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...